The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
New insights into pancreatic cancer-induced paraneoplastic diabetes
Open accessAbstract
Up to 85% of patients with pancreatic cancer have diabetes or hyperglycaemia, which frequently manifests as early as 2–3 years before a diagnosis of pancreatic cancer. Conversely, patients with new-onset diabetes have a 5–8-fold increased risk of being diagnosed with pancreatic cancer within 1–3 years of developing diabetes. Emerging evidence now indicates that pancreatic cancer causes diabetes. As in type 2 diabetes, β-cell dysfunction and peripheral insulin resistance are seen in pancreatic cancer-induced diabetes. However, unlike in patients with type 2 diabetes, glucose control worsens in patients with pancreatic cancer in the face of ongoing, often profound, weight loss. Diabetes and weight loss, which precede cachexia onset by several months, are paraneoplastic phenomena induced by pancreatic cancer. Although the pathogenesis of these pancreatic cancer-induced metabolic alterations is only beginning to be understood, these are likely mechanisms to promote the survival and growth of pancreatic cancer in a hostile and highly desmoplastic microenvironment. Interestingly, these metabolic changes could enable early diagnosis of pancreatic cancer, if they can be distinguished from the ones that occur in patients with type 2 diabetes. One such possible biomarker is adrenomedullin, which is a potential mediator of β-cell dysfunction in pancreatic cancer-induced diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
Subcutaneous and visceral adipose tissue: Structural and functional differences
Ibrahim, M. M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00623.x · Cited by 2,238
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Understanding the mechanisms and treatment options in cancer cachexia
Fearon, K., Arends, J., & Baracos, V. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.209 · Cited by 940
Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease
Klein, S., Fontana, L., Young, V. L., Coggan, A. R., Kilo, C., Patterson, B. W., & Mohammed, B. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033179 · Cited by 917
Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis
Everhart, J. (1995) · JAMA · doi:10.1001/jama.273.20.1605 · Cited by 742
Conlon, K. C., Klimstra, D. S., & Brennan, M. F. (1996) · Annals of Surgery · doi:10.1097/00000658-199603000-00007 · Cited by 709
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
Ben, Q., Xu, M., Ning, X., Liu, J., Hong, S., Huang, W., Zhang, H., & Li, Z. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.003 · Cited by 685
Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.039 · Cited by 621
Self-citationProbability of Pancreatic Cancer Following Diabetes: A Population-Based Study
Chari, S. T., Leibson, C. L., Rabe, K. G., Ransom, J., de Andrade, M., & Petersen, G. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.007 · Cited by 603
Self-citationAntidiabetic Therapies Affect Risk of Pancreatic Cancer
Li, D., Yeung, S. J., Hassan, M. M., Konopleva, M., & Abbruzzese, J. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.013 · Cited by 584
What causes the insulin resistance underlying obesity?
Hardy, O. T., Czech, M. P., & Corvera, S. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283514e13 · Cited by 563
Removal of Visceral Fat Prevents Insulin Resistance and Glucose Intolerance of Aging
Gabriely, I., Ma, X. H., Yang, X. M., Atzmon, G., Rajala, M. W., Berg, A. H., Scherer, P., Rossetti, L., & Barzilai, N. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2951 · Cited by 563
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Pannala, R., Basu, A., Petersen, G. M., & Chari, S. T. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70337-1 · Cited by 558
Self-citationThe metabolic syndrome and adipocytokines
Matsuzawa, Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.028 · Cited by 542
Chari, S. T., Leibson, C. L., Rabe, K. G., Timmons, L. J., Ransom, J., de Andrade, M., & Petersen, G. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.040 · Cited by 517
Self-citationKoerner, A., Kratzsch, J., & Kiess, W. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.008 · Cited by 471
McLaughlin, T., Lamendola, C., Liu, A., & Abbasi, F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0615 · Cited by 468
Thörne, A., Lönnqvist, F., Apelman, J., Hellers, G., & Arner, P. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801871 · Cited by 463
Wang, C., Wang, X., Gong, G., Ben, Q., Qiu, W., Chen, Y., Li, G., & Wang, L. (2012) · International Journal of Cancer · doi:10.1002/ijc.26165 · Cited by 449
Matsuzawa, Y., Funahashi, T., & Nakamura, T. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7922 · Cited by 446
Insulin, Glucose, Insulin Resistance, and Pancreatic Cancer in Male Smokers
Stolzenberg-Solomon, R. Z. (2005) · JAMA · doi:10.1001/jama.294.22.2872 · Cited by 400
Akakura, N., Kobayashi, M., Horiuchi, I., Suzuki, A., Wang, J., Chen, J., Niizeki, H., Ki, K., Hosokawa, M., & Asaka, M. (2001) · PubMed · Cited by 400
Is Diabetes Mellitus an Independent Risk Factor for Colon Cancer and Rectal Cancer?
Yuhara, H., Steinmaus, C., Cohen, S. E., Corley, D. A., Tei, Y., & Buffler, P. A. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.301 · Cited by 377
Collective Review of Small Carcinomas of the Pancreas
TSUCHIYA, R., TOMIOKA, T., IZAWA, K., NODA, T., YAMAMOTO, K., TSUNODA, T., HARADA, N., YAMAGUCHI, T., YOSHINO, R., MIYAMOTO, T., et al. (1986) · Annals of Surgery · doi:10.1097/00000658-198601000-00013 · Cited by 348
The clinical significance of pancreatic steatosis
Smits, M. M., & van Geenen, E. J. M. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.4 · Cited by 325
Diabetes and pancreatic cancer
Li, D. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.20771 · Cited by 315
Selective Insulin and Leptin Resistance in Metabolic Disorders
Könner, A. C., & Brüning, J. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.004 · Cited by 303
Samaras, K., Botelho, N. K., Chisholm, D. J., & Lord, R. V. (2010) · Obesity · doi:10.1038/oby.2009.443 · Cited by 287
The Inflammasome Puts Obesity in the Danger Zone
Stienstra, R., Tack, C. J., Kanneganti, T.-D., Joosten, L. A. B., & Netea, M. G. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.011 · Cited by 271
Insulin resistance and cancer: The role of insulin and IGFs
Djiogue, S., Nwabo Kamdje, A. H., Vecchio, L., Kipanyula, M. J., Farahna, M., Aldebasi, Y., & Seke Etet, P. F. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0324 · Cited by 263
Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes
Hermans, M. P., Levy, J. C., Morris, R. J., & Turner, R. C. (1999) · Diabetologia · doi:10.1007/s001250051215 · Cited by 260
Pancreatogenic Diabetes: Special Considerations for Management
Cui, Y., & Andersen, D. K. (2011) · Pancreatology · doi:10.1159/000329188 · Cited by 256
Gangi, S., Fletcher, J. G., Nathan, M. A., Christensen, J. A., Harmsen, W. S., Crownhart, B. S., & Chari, S. T. (2004) · American Journal of Roentgenology · doi:10.2214/ajr.182.4.1820897 · Cited by 249
Self-citationRozengurt, E., Sinnett-Smith, J., & Kisfalvi, K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2229 · Cited by 247
Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer
Permert, J., Ihse, I., Jorfeldt, L., von Schenck, H., Arnquist, H. J., & Larsson, J. (1993) · Journal of British Surgery · doi:10.1002/bjs.1800800841 · Cited by 244
Islet Amyloid Polypeptide in Patients with Pancreatic Cancer and Diabetes
Permert, J., Larsson, J., Westermark, G. T., Herrington, M. K., Christmanson, L., Pour, P. M., Westermark, P., & Adrian, T. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402033300503 · Cited by 242
Chaika, N. V., Gebregiworgis, T., Lewallen, M. E., Purohit, V., Radhakrishnan, P., Liu, X., Zhang, B., Mehla, K., Brown, R. B., Caffrey, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203339109 · Cited by 227
(1993) · PubMed · Cited by 222
GLENN, F., & THORBJARNARSON, B. (1964) · Annals of Surgery · doi:10.1097/00000658-196406000-00011 · Cited by 221
Adiponectin: A Key Player in Obesity Related Disorders
Matsuzawa, Y. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791208893 · Cited by 203
Regulation of insulin secretion and blood glucose metabolism by adrenomedullin
Martinez, A. (1996) · Endocrinology · doi:10.1210/en.137.6.2626 · Cited by 195
Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed?
Hardt, P. D., Brendel, M. D., Kloer, H. U., & Bretzel, R. G. (2008) · Diabetes Care · doi:10.2337/dc08-s244 · Cited by 194
Pancreatic cancer, alcohol, diabetes mellitus and gall‐bladder disease
Cuzick, J., & Babiker, A. G. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430312 · Cited by 194
The ratio of leptin to adiponectin can be used as an index of insulin resistance
Oda, N., Imamura, S., Fujita, T., Uchida, Y., Inagaki, K., Kakizawa, H., Hayakawa, N., Suzuki, A., Takeda, J., Horikawa, Y., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2007.09.011 · Cited by 192
Detecting Early Pancreatic Cancer: Problems and Prospects
Chari, S. T. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.05.005 · Cited by 191
Self-citationHermans, M. P., Levy, J. C., Morris, R. J., & Turner, R. C. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1779 · Cited by 186
Pelaez-Luna, M., Takahashi, N., Fletcher, J. G., & Chari, S. T. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01480.x · Cited by 180
Self-citationPancreatic Cancer as a Model: Inflammatory Mediators, Acute‐phase Response, and Cancer Cachexia
Fearon, K. C. H., Barber, M. D., Falconer, J. S., McMillan, D. C., Ross, J. A., & Preston, T. (1999) · World Journal of Surgery · doi:10.1007/pl00012351 · Cited by 175
de Boer, M. P., Meijer, R. I., Wijnstok, N. J., Jonk, A. M., Houben, A. J. H. M., Stehouwer, C. D. A., Smulders, Y. M., Eringa, E. C., & Serné, E. H. (2011) · Microcirculation · doi:10.1111/j.1549-8719.2011.00130.x · Cited by 171
Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem
Tsoli, M., & Robertson, G. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.10.006 · Cited by 170
Chen, J., Zhao, S., Nakada, K., Kuge, Y., Tamaki, N., Okada, F., Wang, J., Shindo, M., Higashino, F., Takeda, K., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63924-7 · Cited by 170
Aggarwal, G., Ramachandran, V., Javeed, N., Arumugam, T., Dutta, S., Klee, G. G., Klee, E. W., Smyrk, T. C., Bamlet, W., Han, J. J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.044 · Cited by 170
Self-citationMurphy, R. A., Wilke, M. S., Perrine, M. F., Pawłowicz, M., Mourtzakis, M., Lieffers, J. R. L., Maneshgar, M., Bruera, E. D., Clandinin, M. T., Baracos, V. E., et al. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.11.006 · Cited by 169
S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis
Arumugam, T., Ramachandran, V., Gomez, S. B., Schmidt, A. M., & Logsdon, C. D. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0221 · Cited by 167
Prevalence of Diabetes Mellitus in Pancreatic Cancer Compared to Common Cancers
Aggarwal, G., Kamada, P., & Chari, S. T. (2013) · Pancreas · doi:10.1097/mpa.0b013e3182592c96 · Cited by 167
Self-citationKang, R., Loux, T., Tang, D., Schapiro, N. E., Vernon, P., Livesey, K. M., Krasinskas, A., Lotze, M. T., & Zeh, H. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113865109 · Cited by 163
Establishment of a concept of visceral fat syndrome and discovery of adiponectin
MATSUZAWA, Y. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.131 · Cited by 163
Han, L., Ma, Q., Li, J., Liu, H., Li, W., Ma, G., Xu, Q., Zhou, S., & Wu, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027074 · Cited by 162
Diabetes and pancreatic cancer
Cui, Y., & Andersen, D. K. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-12-0105 · Cited by 159
Obesity and cancer: the risks, science, and potential management strategies.
McTiernan, A. (2005) · PubMed · Cited by 154
Radiosurgery of acoustic neurinomas
Flíckinger, J. C., Lunsford, L. D., Coffey, R. J., Linskey, M. E., Bissonette, D. J., Maitz, A. H., & Kondziolka, D. S. (1991) · Cancer · doi:10.1002/1097-0142(19910115)67:2<486::aid-cncr2820670228>3.0.co;2-1 · Cited by 149
The pharmacology of Adrenomedullin 2/Intermedin
Hong, Y., Hay, D. L., Quirion, R., & Poyner, D. R. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01530.x · Cited by 144
BELL, E. T. (1957) · PubMed · Cited by 142
Diabetes and Pancreatic Cancer: Chicken or Egg?
Magruder, J. T., Elahi, D., & Andersen, D. K. (2011) · Pancreas · doi:10.1097/mpa.0b013e318209e05d · Cited by 140
Grote, V. A., Rohrmann, S., Nieters, A., Dossus, L., Tjønneland, A. M., Halkjær, J., Overvad, K., Fagherazzi, G., Boutron‐Ruault, M., Morois, S., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2316-0 · Cited by 138
New-Onset Diabetes and Pancreatic Cancer
Gupta, S. N., Vittinghoff, E., Bertenthal, D., Corley, D. A., Shen, H., Walter, L. C., & McQuaid, K. R. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.06.024 · Cited by 137
Cancer risks in LKB1 germline mutation carriers
Mehenni, H., Resta, N., Park, J.-G., Miyaki, M., Guanti, G., & Costanza, M. C. (2006) · Gut · doi:10.1136/gut.2005.082990 · Cited by 129
The role of fat topology in the risk of disease
Matsuzawa, Y. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.243 · Cited by 126
Long-term survival after curative resection for pancreatic ductal adenocarcinoma
Sakar, B., Aykan, N. F., Sağlam, S., & Üstüner, Z. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.4227 · Cited by 123
Genome profiling of pancreatic adenocarcinoma
Birnbaum, D. J., Adélaïde, J., Mamessier, E., Finetti, P., Lagarde, A., Monges, G., Viret, F., Gonçalvès, A., Turrini, O., Delpero, J., et al. (2011) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20870 · Cited by 122
Pannala, R., Leibson, C. L., Rabe, K. G., Timmons, L. J., Ransom, J. E., de Andrade, M., Petersen, G. M., & Chari, S. T. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.253 · Cited by 120
Self-citationDing, X., Fehsenfeld, D. M., Murphy, L. O., Permert, J., & Adrian, T. E. (2000) · Pancreas · doi:10.1097/00006676-200010000-00014 · Cited by 115
Schwartz, S. S., Zeidler, A., Moossa, A. R., Kuku, S. F., & Rubenstein, A. H. (1978) · Digestive Diseases and Sciences · doi:10.1007/bf01072886 · Cited by 113
Wang, F., Gupta, S. N., & Holly, E. A. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0188 · Cited by 113
Over-nutrition, Obesity and Insulin Resistance in the Development of β-Cell Dysfunction
Gupta, D., Krueger, C. B., & Lastra, G. (2012) · Current Diabetes Reviews · doi:10.2174/157339912799424564 · Cited by 112
Ogawa, Y., Tanaka, M., Inoue, K., Yamaguchi, K., Chijiiwa, K., Mizumoto, K., Tsutsu, N., & Nakamura, Y. (2002) · Cancer · doi:10.1002/cncr.10493 · Cited by 108
Bonelli, L. A., Aste, H., Bovo, P., Cavallini, G., Felder, M., Gusmaroli, R., Morandini, E., Ravelli, P., Briglia, R., Lombardo, L., et al. (2003) · Pancreas · doi:10.1097/00006676-200308000-00007 · Cited by 107
Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion
Keleg, S., Kayed, H., Jiang, X., Penzel, R., Giese, T., Büchler, M. W., Frieß, H., & Kleeff, J. H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22596 · Cited by 106
Li, D., Duell, E. J., Yu, K. F., Risch, H. A., Olson, S. H., Kooperberg, C. L., Wolpin, B. M., Jiao, L., Dong, X., Wheeler, B., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs151 · Cited by 106
Chaika, N. V., Yu, F., Purohit, V., Mehla, K., Lazenby, A. J., DiMaio, D. J., Anderson, J. M., Yeh, J. J., Johnson, K. R., Hollingsworth, M. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032996 · Cited by 105
Pancreatic duct replication is increased with obesity and type 2 diabetes in humans
Butler, A. E., Galasso, R., Matveyenko, A. V., Rizza, R. A., Dry, S., & Butler, P. C. (2009) · Diabetologia · doi:10.1007/s00125-009-1556-8 · Cited by 104
New-onset diabetes in pancreatic cancer: A study in the primary care setting
Aggarwal, G., Rabe, K. G., Petersen, G. M., & Chari, S. T. (2012) · Pancreatology · doi:10.1016/j.pan.2012.02.003 · Cited by 99
Self-citationWeight Loss Precedes Cancer-Specific Symptoms in Pancreatic Cancer-Associated Diabetes Mellitus
Hart, P. A., Kamada, P., Rabe, K. G., Srinivasan, S., Basu, A., Aggarwal, G., & Chari, S. T. (2011) · Pancreas · doi:10.1097/mpa.0b013e318220816a · Cited by 99
Self-citationPancreatic cancer, blood glucose and beverage consumption
Hiatt, R. A., Klatsky, A. L., & Armstrong, M. A. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410603 · Cited by 94
Zinc-α2-glycoprotein: an adipokine modulator of body fat mass?
Bing, C., Mráček, T., Gao, D., & Trayhurn, P. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.105 · Cited by 89
Marble, A. (1934) · New England Journal of Medicine · doi:10.1056/nejm193408232110801 · Cited by 88
The Intracellular Mechanism of Insulin Resistance in Pancreatic Cancer Patients
Liu, J., Knezetic, J. A., Strömmer, L., Permert, J., Larsson, J., & Adrian, T. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6400 · Cited by 85
Pancreatic cancer-derived S-100A8 N-terminal peptide: A diabetes cause?
Basso, D., Greco, E., Fogar, P., Pucci, P., Flagiello, A., Baldo, G., Giunco, S., Valerio, A., Navaglia, F., Zambon, C., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.03.027 · Cited by 85
Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer
Chari, S. T., Klee, G. G., Miller, L. J., Raimondo, M., & DiMagno, E. P. (2001) · Gastroenterology · doi:10.1053/gast.2001.27210 · Cited by 85
Self-citationChari, S. T., Zapiach, M., Yadav, D., & Rizza, R. A. (2005) · Pancreatology · doi:10.1159/000085276 · Cited by 83
Self-citationPast Medical History and Pancreatic Cancer Risk: Results From a Multicenter Case-Control Study
Maisonneuve, P., Lowenfels, A. B., Bueno-de-Mesquita, H. B., Ghadirian, P., Baghurst, P., Zatoński, W. A., Miller, A. B., Duell, E. J., Boffetta, P., & Boyle, P. (2010) · Annals of Epidemiology · doi:10.1016/j.annepidem.2009.11.010 · Cited by 82
Diabetes Mellitus in Association with Primary Carcinoma of the Pancreas
Green, R. C., Baggenstoss, A. H., & Sprague, R. G. (1958) · Diabetes · doi:10.2337/diab.7.4.308 · Cited by 82
Putative Pancreatic Cancer-Associated Diabetogenic Factor: 2030 MW Peptide
Basso, D., Valerio, A., Seraglia, R., Mazza, S., Piva, M. G., Greco, E., Fogar, P., Gallo, N., Pedrazzoli, S., Tiengo, A., et al. (2002) · Pancreas · doi:10.1097/00006676-200201000-00002 · Cited by 77
Natsuizaka, M., Ozasa, M., Darmanin, S., Miyamoto, M., Kondo, S., Kamada, S., Shindoh, M., Higashino, F., Suhara, W., Koide, H., et al. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.06.013 · Cited by 76
Jiao, L., Taylor, P. R., Weinstein, S. J., Graubard, B. I., Virtamo, J. R. K., Albanes, D., & Stolzenberg‐Solomon, R. Z. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0066 · Cited by 75
Jiao, L., Weinstein, S. J., Albanes, D., Taylor, P. R., Graubard, B. I., Virtamo, J. R. K., & Stolzenberg‐Solomon, R. Z. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2573 · Cited by 74
Pancreatic cancer cells selectively stimulate islet β cells to secrete amylin
Ding, X., Flatt, P. R., Permert, J., & Adrian, T. E. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70641-9 · Cited by 73
Visceral adiposity in gastrointestinal and hepatic carcinogenesis
Vongsuvanh, R., George, J., Qiao, L., & van der Poorten, D. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.038 · Cited by 73
Grote, V. A., Kaaks, R., Nieters, A., Tjønneland, A. M., Halkjær, J., Overvad, K., Nielsen, M. R. S., Boutron‐Ruault, M., Clavel‐Chapelon, F., Racine, A., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.172 · Cited by 67
MicroRNAs in pancreatic cancer metabolism
Singh, P. K., Brand, R. E., & Mehla, K. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.63 · Cited by 62
Islet Hormone Secretion in Pancreatic Cancer Patients with Diabetes
Permert, J., Larsson, D. G. J., Fruin, A. B., Tatemoto, K., Herrington, M. K., von Schenck, H., & Adrian, T. E. (1997) · Pancreas · doi:10.1097/00006676-199707000-00009 · Cited by 61
Li, J., Ma, Q., Liu, H., Guo, K., Li, F., Li, W., Han, L., Wang, F., & Wu, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017385 · Cited by 60
Basso, D., Brigato, L., Veronesi, A., Panozzo, M., Amadori, A., & Plebani, M. (1995) · PubMed · Cited by 59
Regulation of pancreatic physiology by adrenomedullin and its binding protein
Zudaire, E., Cuttitta, F. F., & Martínez, A. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00030-2 · Cited by 54
The Intracellular Mechanism of Insulin Resistance in Pancreatic Cancer Patients
Liu, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1232 · Cited by 53
Basso, D., Millino, C., Greco, E., Romualdi, C., Fogar, P., Valerio, A., Bellin, M., Zambon, C., Navaglia, F., Dussini, N., et al. (2004) · Gut · doi:10.1136/gut.2003.024471 · Cited by 50
Wu, J., Kuo, T., Yang, C., Chiang, P., Jeng, Y., Huang, P., & Tien, Y. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2577-y · Cited by 48
Isaksson, B., Strömmer, L., Friess, H., Büchler, M. W., Herrington, M. K., Wang, F., Zierath, J. R., Wallberg‐Henriksson, H., Larsson, J., & Permert, J. (2003) · Pancreas · doi:10.1097/00006676-200303000-00014 · Cited by 48
Cases and Observations Connected with Disease of the Pancreas and Duodenum
Bright, R. (1833) · Journal of the Royal Society of Medicine · doi:10.1177/09595287330180p102 · Cited by 46
The Complex Exocrine–Endocrine Relationship and Secondary Diabetes in Exocrine Pancreatic Disorders
Chen, N., Ranjit Unnikrishnan, I., Anjana, R. M., Mohan, V., & Pitchumoni, C. S. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822a2ae5 · Cited by 44
Valerio, A., Basso, D., Brigato, L., Ceolotto, G., Baldo, G., Tiengo, A., & Plebani, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0521 · Cited by 44
Expression and Regulatory Role of GAIP-Interacting Protein GIPC in Pancreatic Adenocarcinoma
Muders, M. H., Dutta, S. K., Wang, L., Lau, J. S., Bhattacharya, R., Smyrk, T. C., Chari, S. T., Datta, K., & Mukhopadhyay, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2321 · Cited by 43
Self-citationIn VitroInfluences between Pancreatic Adenocarcinoma Cells and Pancreatic Islets
Wang, F., Larsson, J., Adrian, T. E., Gasslander, T., & Permert, J. (1998) · Journal of Surgical Research · doi:10.1006/jsre.1998.5393 · Cited by 43
Grote, V. A., Nieters, A., Kaaks, R., Tjønneland, A. M., Roswall, N., Overvad, K., Nielsen, M. R. S., Clavel‐Chapelon, F., Boutron‐Ruault, M., Racine, A., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1139 · Cited by 42
GRAUER, F. W. (1939) · Archives of Internal Medicine · doi:10.1001/archinte.1939.00180220074007 · Cited by 39
Basso, D., Valerio, A., Brigato, L., Panozzo, M. P., Miola, M., Lucca, T., Ujka, F., Zaninotto, M., Avogaro, A., & Plebani, M. (1997) · Pancreas · doi:10.1097/00006676-199708000-00004 · Cited by 39
Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus
Krechler, T., Zeman, M., Vecka, M., Macášek, J., Jáchymová, M., Zima, T., & Žák, A. (2010) · Neoplasma · doi:10.4149/neo_2011_01_58 · Cited by 38
β-Cell Function in Pancreatic Adenocarcinoma
Basso, D., Plebani, M., Fogar, P., Favero, G. D., Briani, G., Meggiato, T., Panozzo, M. P., Ferrara, C., D'Angeli, F., & Burlina, A. (1994) · Pancreas · doi:10.1097/00006676-199405000-00008 · Cited by 37
Wang, F., Larsson, J., Abdiu, A., Gasslander, T., Westermark, P., Adrian, T. E., & Permert, J. (1997) · International Journal of Pancreatology · doi:10.1007/bf02822387 · Cited by 36
Pancreatic cancer-associated diabetes mellitus: An open field for proteomic applications
Basso, D., Greco, E., Fogar, P., Pucci, P., Flagiello, A., Baldo, G., Giunco, S., Valerio, A., Navaglia, F., Zambon, C., et al. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.03.025 · Cited by 36
Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster
Ahrén, B., & Andrén-Sandberg, Å. (1993) · Research in Experimental Medicine · doi:10.1007/bf02576207 · Cited by 30
Adrenomedullin inhibits insulin exocytosis via pertussis toxin-sensitive G protein-coupled mechanism
Sekine, N., Takano, K., Kimata-Hayashi, N., Kadowaki, T., & Fujita, T. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00213.2005 · Cited by 30
Pancreatic carcinoma: differences between patients with or without diabetes mellitus.
Girelli, C. M., Reguzzoni, G., Limido, E., Savastano, A., & Rocca, F. L. (1995) · PubMed · Cited by 30
Energy metabolism and proliferation in pancreatic carcinogenesis
Regel, I., Kong, B., Raulefs, S., Erkan, M., Michalski, C. W., Hartel, M., & Kleeff, J. H. (2012) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-012-0933-9 · Cited by 27
Glucose Metabolism Gene Variants Modulate the Risk of Pancreatic Cancer
Dong, X., Li, Y., Chang, P., Tang, H., Hess, K. R., Abbruzzese, J. L., & Li, D. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0247 · Cited by 27
Insulin Therapy and Cancer in Type 2 Diabetes
Mannucci, E. (2012) · ISRN Endocrinology · doi:10.5402/2012/240634 · Cited by 26
Islet amyloid polypeptide (IAPP/amylin) causes insulin resistance in perfused rat hindlimb muscle
Tabata, H., Hirayama, J., Sowa, R., Furuta, H., Negoro, T., Sanke, T., & Nanjo, K. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90068-3 · Cited by 21
Diabetes Mellitus in Pancreatic Cancer Patients in the Czech Republic: Sex Differences
Trna, J., Dítě, P., Adamcová, A., Crawford, B. J., & Hermanová, M. (2012) · Experimental Diabetes Research · doi:10.1155/2012/414893 · Cited by 13
Glucose as a Mitogenic Hormone
Ferrer, J. P. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.014 · Cited by 7
Research works printed but not linked: 12
- De Nunzio, C. & Tubaro, A. Prostate cancer: diabetes and prostate cancer—an open debate. Nat. Rev. Urol. 10, 12–14 (2012). · DOI
- Saruc, M. & Pour, P. M. Diabetes and its relationship to pancreatic carcinoma. Pancreas 26, 381–387 (2003). · doi:10.1097/00006676-200305000-00012
- Kim, T. D. et al. Clinical characteristics of pancreatic cancer according to the presence of diabetes mellitus [Korean]. Korean J. Gastroenterol. 43, 35–40 (2004).
- Permert, J. et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur. J. Surg. 159, 101–107 (1993).
- Rosa, J. A., Van Linda, B. M. & Abourizk, N. N. New-onset diabetes mellitus as a harbinger of pancreatic carcinoma. A case report and literature review. J. Clin. Gastroenterol. 11, 211–215 (1989). · doi:10.1097/00004836-198904000-00020
- Silverstein, M. D., Richter, J. M., Podolsky, D. K. & Warshaw, A. L. Suspected pancreatic cancer presenting as pain or weight loss: analysis of diagnostic strategies. World J. Surg. 8, 839–845 (1984). · doi:10.1007/bf01656023
- Permert, J. et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N. Engl. J. Med. 330, 313–318 (1994). · DOI · Paper page
- Wang, F., Adrian, T. E., Westermark, G., Gasslander, T. & Permert, J. Dissociated insulin and islet amyloid polypeptide secretion from isolated rat pancreatic islets cocultured with human pancreatic adenocarcinoma cells. Pancreas 18, 403–409 (1999). · doi:10.1097/00006676-199905000-00012
- Tisdale, M. J. Zinc- α-2-glycoprotein in cachexia and obesity. Curr. Opin. Support Palliat. Care 3, 288–293 (2009). · doi:10.1097/spc.0b013e328331c897
- Jiao, L. et al. Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study. Cancer Res. 71, 3582–3589 (2011). · DOI
- Permert, J., Herrington, M., Kazakoff, K., Pour, P. M. & Adrian, T. E. Early changes in islet hormone secretion in the hamster pancreatic cancer model. Teratog. Carcinog. Mutagen. 21, 59–67 (2001). · doi:10.1002/1520-6866(2001)21:1<59::aid-tcm6>3.0.co;2-v
- Pour, P. M. & Bell, R. H. Alteration of pancreatic endocrine cell patterns and their secretion during pancreatic carcinogenesis in the hamster model. Cancer Res. 49, 6396–6400 (1989).
Cited by
Kamisawa, T., Wood, L. D., Itoi, T., & Takaori, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00141-0 · Cited by 2,212
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Tempero, M. A., Malafa, M. P., Al-Hawary, M., Behrman, S. W., Benson, A. B., Cardin, D. B., Chiorean, E. G., Chung, V., Czito, B., Del Chiaro, M., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0017 · Cited by 1,304
Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment
Wood, L. D., Canto, M. I., Jaffee, E. M., & Simeone, D. M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.03.056 · Cited by 865
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Singhi, A. D., Koay, E. J., Chari, S. T., & Maitra, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.259 · Cited by 841
Self-citation
Metadata
- Authors
- Sah, R. P., Nagpal, S. J. S., Mukhopadhyay, D., & Chari, S. T.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2013-03-26
- Volume
- 10
- Issue
- 7
- Pages
- 423-433
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2033654850
- Cited by
- 334
- References
- 141
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.